Trastuzumab Deruxtecan for HER2‐Low Metastatic Breast Cancer: Practical Considerations for Medical Oncologists and Pathologists in Australia.
Saved in:
| Title: | Trastuzumab Deruxtecan for HER2‐Low Metastatic Breast Cancer: Practical Considerations for Medical Oncologists and Pathologists in Australia. |
|---|---|
| Authors: | Redfern, Andrew1,2,3 (AUTHOR) Andrew.Redfern@health.wa.gov.au, Lim, Elgene4,5 (AUTHOR), Lakhani, Sunil6,7 (AUTHOR), Pathmanathan, Nirmala8,9,10 (AUTHOR), Selva‐Nayagam, Sudarsha11 (AUTHOR), McCarthy, Nicole12,13 (AUTHOR), Yeo, Belinda14,15 (AUTHOR), Dessauvagie, Benjamin16,17 (AUTHOR), Farshid, Gelareh18,19 (AUTHOR) |
| Source: | Asia Pacific Journal of Clinical Oncology. Jun2026, Vol. 22 Issue 3, p381-391. 11p. |
| Database: | Academic Search Ultimate |
| ISSN: | 17437555 |
|---|---|
| DOI: | 10.1111/ajco.70069 |
